Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Twist Bioscience Corp (TWST)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $376.6M | $313.0M | $245.1M | $203.6M | $132.3M | $90.1M | $54.4M | $25.4M | $10.8M |
| Research & development | $80.3M | $90.9M | $106.9M | $120.3M | $69.1M | $43.0M | $35.7M | $20.3M | $19.2M |
| Operating income | −$136.3M | −$220.8M | −$217.2M | −$234.8M | −$152.7M | −$140.1M | −$108.8M | −$70.6M | −$58.5M |
| EBITDAderived | −$111.4M | −$189.4M | −$187.8M | −$218.3M | −$143.0M | −$133.4M | −$102.7M | −$64.8M | −$53.5M |
| Net income | −$77.7M | −$208.7M | −$204.6M | −$217.9M | −$152.1M | −$139.9M | −$107.7M | −$71.2M | −$59.3M |
| Basic EPSper diluted share | -$1.30 | -$3.60 | -$3.60 | -$4.04 | -$3.15 | -$3.57 | -$3.92 | -$25.51 | -$24.49 |
| Diluted EPSper diluted share | -$1.30 | -$3.60 | -$3.60 | -$4.04 | -$3.15 | -$3.57 | -$3.92 | -$25.51 | -$24.49 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 25, 2026Form 4 · 10b5-1 | Leproust Emily M.Chief Executive Officer | SellCommon Stock | 18.9K | $95.00 | $1.79M | 824.0K |
| Jun 24, 2026Form 4 · 10b5-1 | Cho DennisSee Remarks | SellCommon Stock | 14.2K | $89.75 | $1.27M | 105.1K |
| Jun 22, 2026Form 4 | Green PaulaSVP of Human Resources | SellCommon Stock | 291 | $87.32 | $25.4K | 120.4K |
| Jun 22, 2026Form 4 | Cho DennisSee Remarks | SellCommon Stock | 346 | $87.32 | $30.2K | 119.3K |
| Jun 22, 2026Form 4 | Leproust Emily M.Chief Executive Officer | SellCommon Stock | 1.7K | $87.32 | $147.4K | 842.9K |